Author of the article:
Published Dec 21, 2024 • 1 minute read
Washington, DC, Dec. 21, 2024 (GLOBE NEWSWIRE) — The National Association of Specialty Pharmacy issued the following statement:
Article content
Article content
As the non-profit trade organization representing specialty pharmacies that support patients with significant and complex diseases (cancer, MS, rheumatoid arthritis, cystic fibrosis, organ transplantation, rare diseases, etc) we are extremely frustrated and disappointed that the new funding bill passed last night does not include PBM reform-related pharmacy protections. Not advancing these needed reforms threatens pharmacy participation in Medicare Part D networks, limits patient access to the pharmacy of their choice, and continues to allow for anticompetitive business practices that threaten the financial solvency of pharmacy businesses throughout the U.S.
Advertisement 2
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world’s leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world’s leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
“As a new Congress begins, it is imperative that the PBM reform-related pharmacy protections be passed into law without any further delay,” said Sheila Arquette, NASP President and CEO. “President-elect Trump has stated this is a policy priority. We value the hard work by so many pharmacy champions in the House and Senate to advance these reforms. These must-pass provisions save taxpayer and government money and have resulted after years of debate and following intentional bipartisan planning by the 118th Congress. The time to act is early in the new congressional session before any more pharmacies go out of business and are acquired – the direct result of abusive PBM practices that must be reigned in without further delay.”
###
NASP represents all specialty pharmacy industry stakeholders. Specialty pharmacies serve communities of patients who have complex health conditions like cancer, rheumatoid arthritis, multiple sclerosis, cystic fibrosis, hemophilia, organ transplantation and rare diseases. Specialty pharmacies are accredited by an independent, third party nationally recognized accreditation organization ensuring consistent quality of extensive drug management and clinical patient care services.
Article content
